VU6010608, a Novel mGlu<sub>7</sub> NAM from a Series of <i>N</i>-(2-(1<i>H</i>-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)benzamides
作者:Carson W. Reed、Kevin M. McGowan、Paul K. Spearing、Branden J. Stansley、Hanna F. Roenfanz、Darren W. Engers、Alice L. Rodriguez、Eileen M. Engelberg、Vincent B. Luscombe、Matthew T. Loch、Daniel H. Remke、Jerri M. Rook、Anna L. Blobaum、P. Jeffrey Conn、Colleen M. Niswender、Craig W. Lindsley
DOI:10.1021/acsmedchemlett.7b00429
日期:2017.12.14
Herein, we report the structure–activity relationships within a series of mGlu7 NAMs based on an N-(2-(1H-1,2,4-triazol-1-yl)-5-(trifluoromethoxy)phenyl)benzamide core with excellent CNS penetration (Kp 1.9–5.8 and Kp,uu 0.4–1.4). Analogues in this series displayed steep SAR. Of these, VU6010608 (11a) emerged with robust efficacy in blocking high frequency stimulated long-term potentiation in electrophysiology
在这里,我们报告一系列基于N-(2-(1 H -1,2,4-三唑-1-基)-5-(三氟甲氧基)苯基)苯甲酰胺核心的mGlu 7 NAM中的结构活性关系具有出色的CNS渗透性(K p 1.9-5.8和K p,uu 0.4-1.4)。该系列中的类似物显示出陡峭的SAR。其中,VU6010608(11a)在阻断电生理研究中的高频刺激的长期增强作用方面表现出强大的功效。